- Learn how AI-driven approaches integrate multiomics data, including genomics, proteomics, and transcriptomics, to identify potential drug targets and disease biomarkers for complex diseases.
 - Explore how AI models synthesize cross-omic data and real-time multiomic information to uncover novel biological mechanisms, identify potential biomarkers and enable precision medicine.
 
Speaker(s): 
Moderator
Raju Pusapati
Vice President, Life Sciences
Solix Technologies Inc.

Kiran Nistala
Head, Functional Genomics
Alkermes

Harris Bell-Temin
Director, Proteomics
Johnson & Johnson Innovative Medicine

Arthur Liberzon
Director, AI Research Lead for Omics, Oncology Data Science
AstraZeneca
Time: 
12:45 PM - 1:15 PM
Agenda Track No.: 
Track 1
Session Type: 
General Session (Presentation)